Subependymal giant cell astrocytoma natural history, complications and prognosis: Difference between revisions

Jump to navigation Jump to search
(Created page with "__NOTOC__ {{Subependymal giant cell astrocytoma}} {{CMG}}{{AE}}{{SR}} ==Reference== {{reflist|2}} Category:Disease Category:Types of cancer Category:Rare disease...")
 
No edit summary
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Subependymal giant cell astrocytoma}}
{{Subependymal giant cell astrocytoma}}
{{CMG}}{{AE}}{{SR}}
==Overview==
==Natural History==
*Subependymal giant cell astrocytoma tends to grow slowly and are less likely to spread.<ref name="RothRoach2013">{{cite journal|last1=Roth|first1=Jonathan|last2=Roach|first2=E. Steve|last3=Bartels|first3=Ute|last4=Jóźwiak|first4=Sergiusz|last5=Koenig|first5=Mary Kay|last6=Weiner|first6=Howard L.|last7=Franz|first7=David N.|last8=Wang|first8=Henry Z.|title=Subependymal Giant Cell Astrocytoma: Diagnosis, Screening, and Treatment. Recommendations From the International Tuberous Sclerosis Complex Consensus Conference 2012|journal=Pediatric Neurology|volume=49|issue=6|year=2013|pages=439–444|issn=08878994|doi=10.1016/j.pediatrneurol.2013.08.017}}</ref>
*If left untreated, patients with subependymal giant cell astrocytoma may progress to cause occlusion of the [[foramen of Monro]], with subsequent elevated intracranial pressure and [[hydrocephalus]], thus necessitating intervention.
==Complication==
==Prognosis==


{{CMG}}{{AE}}{{SR}}


==Reference==
==Reference==

Revision as of 21:02, 2 November 2015

Subependymal giant cell astrocytoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Subependymal Giant Cell Astrocytoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Subependymal giant cell astrocytoma natural history, complications and prognosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Subependymal giant cell astrocytoma natural history, complications and prognosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Subependymal giant cell astrocytoma natural history, complications and prognosis

CDC on Subependymal giant cell astrocytoma natural history, complications and prognosis

Subependymal giant cell astrocytoma natural history, complications and prognosis in the news

Blogs on Subependymal giant cell astrocytoma natural history, complications and prognosis

Directions to Hospitals Treating Ependymoma

Risk calculators and risk factors for Subependymal giant cell astrocytoma natural history, complications and prognosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sujit Routray, M.D. [2]

Overview

Natural History

  • Subependymal giant cell astrocytoma tends to grow slowly and are less likely to spread.[1]
  • If left untreated, patients with subependymal giant cell astrocytoma may progress to cause occlusion of the foramen of Monro, with subsequent elevated intracranial pressure and hydrocephalus, thus necessitating intervention.

Complication

Prognosis

Reference

  1. Roth, Jonathan; Roach, E. Steve; Bartels, Ute; Jóźwiak, Sergiusz; Koenig, Mary Kay; Weiner, Howard L.; Franz, David N.; Wang, Henry Z. (2013). "Subependymal Giant Cell Astrocytoma: Diagnosis, Screening, and Treatment. Recommendations From the International Tuberous Sclerosis Complex Consensus Conference 2012". Pediatric Neurology. 49 (6): 439–444. doi:10.1016/j.pediatrneurol.2013.08.017. ISSN 0887-8994.


Template:WikiDoc Sources